Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2023 | 4 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?
Semin Nucl Med. 2024 Jan;54(1):150-162. doi: 10.1053/j.semnuclmed.2023.06.004. Epub 2023 Jul 1.
Semin Nucl Med. 2024.
PMID: 37394289
Review.
Histology and PSMA Expression on Immunohistochemistry in High-Risk Prostate Cancer Patients: Comparison with 68Ga-PSMA PET/CT Features in Primary Staging.
Vetrone L, Mei R, Bianchi L, Giunchi F, Farolfi A, Castellucci P, Droghetti M, Presutti M, Degiovanni A, Schiavina R, Brunocilla E, D'Errico A, Fanti S.
Vetrone L, et al.
Cancers (Basel). 2023 Mar 10;15(6):1716. doi: 10.3390/cancers15061716.
Cancers (Basel). 2023.
PMID: 36980602
Free PMC article.
Item in Clipboard
A novel tool for predicting the dose distribution of non-sealed 188 Re (Rhenium) resin in non-melanoma skin cancers (NMSC) patients.
Zagni F, Vichi S, Paolani G, Santoro M, Della Gala G, Strolin S, Castellucci P, Vetrone L, Fanti S, Morganti AG, Strigari L.
Zagni F, et al. Among authors: vetrone l.
Med Phys. 2023 Jul;50(7):4600-4612. doi: 10.1002/mp.16346. Epub 2023 Mar 30.
Med Phys. 2023.
PMID: 36919341
Item in Clipboard
Case report: PSMA PET/CT addresses the correct diagnosis in a patient with metastatic prostate cancer despite negative core biopsies and mpMRI. A diagnostic challenge.
Vetrone L, Cuzzani G, Mei R, Zanoni L, Bertaccini A, Bianchi L, Castellucci P, Gaudiano C, Cappelli A, Giunchi F, Fanti S.
Vetrone L, et al.
Front Oncol. 2023 Feb 7;13:1101221. doi: 10.3389/fonc.2023.1101221. eCollection 2023.
Front Oncol. 2023.
PMID: 36824128
Free PMC article.
Item in Clipboard
Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma.
De Felice F, Vetrone L, Bulzonetti N, Caiazzo R, Marampon F, Musio D, Tombolini V.
De Felice F, et al. Among authors: vetrone l.
Med Oncol. 2019 Jun 12;36(8):68. doi: 10.1007/s12032-019-1292-y.
Med Oncol. 2019.
PMID: 31190132
Clinical Trial.
Item in Clipboard
Cite
Cite